Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis
The high prevalence of early-diabetes in patients with pancreatic cancer (PanC) implies that its recognition could help identify people at high risk of developing PanC. Candidate microRNAs (miRNAs) associated with recent diabetes were screened from our previous miRNA expression profiling on 10 pools...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01567/full |
| _version_ | 1818527848698216448 |
|---|---|
| author | Francesca Tavano Andrea Fontana Tommaso Mazza Domenica Gioffreda Tommaso Biagini Orazio Palumbo Massimo Carella Angelo Andriulli |
| author_facet | Francesca Tavano Andrea Fontana Tommaso Mazza Domenica Gioffreda Tommaso Biagini Orazio Palumbo Massimo Carella Angelo Andriulli |
| author_sort | Francesca Tavano |
| collection | DOAJ |
| description | The high prevalence of early-diabetes in patients with pancreatic cancer (PanC) implies that its recognition could help identify people at high risk of developing PanC. Candidate microRNAs (miRNAs) associated with recent diabetes were screened from our previous miRNA expression profiling on 10 pools of plasma from PanC patients and non-PanC controls, both including also subjects with early- and late-diabetes. The droplet digital PCR (ddPCR) was used to re-test candidate miRNAs in a new independent cohort of 69 subjects (40 PanC, 29 non-PanC) with early- (17 PanC, 13 non-PanC) or late-diabetes (23 PanC, 16 non-PanC), and in 100 non-diabetic healthy subjects (HS). miRNA levels were evaluated for differences between subjects enrolled into the study and for their diagnostic performance, also compared to the CA 19-9 determinations. MiR-20b-5p, miR-29a, and miR-18a-5p were selected from the previous miRNA expression profiling. The ddPCR confirmed the increase of miR-20b-5p and miR-29a levels in PanC with early- compared to those with late-diabetes. Conversely, miR-20b-5p, miR-29a, and miR-18a-5p were over-expressed in both PanC and non-PanC with recent diabetes compared to HS, and each miRNA achieved a similar diagnostic performance in distinguishing either PanC or non-PanC with early-diabetes from HS (miR-20b-5p: AUC = 0.877 vs. AUC = 0.873; miR-29a: AUC = 0.838 vs. AUC = 0.810; miR-18a-5p: AUC = 0.824 vs. AUC = 0.875). Despite miR-20b-5p and miR-29a expressions were also higher both in PanC and non-PanC with late-diabetes with respect to HS, the diagnostic accuracy in PanC with late-diabetes vs. HS reached by each miRNA (miR-20b-5p: AUC = 0.760; miR-29a: AUC = 0.630) was lower than the ones achieved in PanC with early-diabetes vs. HS. Furthermore, miR-20b-5p achieved a higher diagnostic accuracy to discriminate non-PanC with early-diabetes from HS (AUC = 0.868; SP = 81%; PPV = 32.1%) compared to the CA 19-9 (AUC = 0.700; SP = 40.0%; PPV = 15.5%), and the joint (miR-20b-5p and CA 19-9) discrimination ability was higher than the one achieved by the CA 19-9 tested alone (AUC = 0.900, p = 0.003). Our data highlighted the association between miR-18a-5p and early-diabetes, and suggested for miR-20b-5p and miR-29 a role in identifying early diabetes in PanC, albeit not as an early manifestation of cancer. MiR-20b-5p as more informative marker than CA 19-9 in distinguishing non-PanC with recent diabetes from HS was also uncovered. |
| first_indexed | 2024-12-11T06:41:42Z |
| format | Article |
| id | doaj.art-87bdd81ca29244c382bdbb1efc92e438 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-11T06:41:42Z |
| publishDate | 2020-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-87bdd81ca29244c382bdbb1efc92e4382022-12-22T01:17:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-09-011010.3389/fonc.2020.01567550089Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent DiagnosisFrancesca Tavano0Andrea Fontana1Tommaso Mazza2Domenica Gioffreda3Tommaso Biagini4Orazio Palumbo5Massimo Carella6Angelo Andriulli7Division of Gastroenterology and Research Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyUnit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyUnit of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyDivision of Gastroenterology and Research Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyUnit of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyDivision of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyDivision of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyDivision of Gastroenterology and Research Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, Foggia, ItalyThe high prevalence of early-diabetes in patients with pancreatic cancer (PanC) implies that its recognition could help identify people at high risk of developing PanC. Candidate microRNAs (miRNAs) associated with recent diabetes were screened from our previous miRNA expression profiling on 10 pools of plasma from PanC patients and non-PanC controls, both including also subjects with early- and late-diabetes. The droplet digital PCR (ddPCR) was used to re-test candidate miRNAs in a new independent cohort of 69 subjects (40 PanC, 29 non-PanC) with early- (17 PanC, 13 non-PanC) or late-diabetes (23 PanC, 16 non-PanC), and in 100 non-diabetic healthy subjects (HS). miRNA levels were evaluated for differences between subjects enrolled into the study and for their diagnostic performance, also compared to the CA 19-9 determinations. MiR-20b-5p, miR-29a, and miR-18a-5p were selected from the previous miRNA expression profiling. The ddPCR confirmed the increase of miR-20b-5p and miR-29a levels in PanC with early- compared to those with late-diabetes. Conversely, miR-20b-5p, miR-29a, and miR-18a-5p were over-expressed in both PanC and non-PanC with recent diabetes compared to HS, and each miRNA achieved a similar diagnostic performance in distinguishing either PanC or non-PanC with early-diabetes from HS (miR-20b-5p: AUC = 0.877 vs. AUC = 0.873; miR-29a: AUC = 0.838 vs. AUC = 0.810; miR-18a-5p: AUC = 0.824 vs. AUC = 0.875). Despite miR-20b-5p and miR-29a expressions were also higher both in PanC and non-PanC with late-diabetes with respect to HS, the diagnostic accuracy in PanC with late-diabetes vs. HS reached by each miRNA (miR-20b-5p: AUC = 0.760; miR-29a: AUC = 0.630) was lower than the ones achieved in PanC with early-diabetes vs. HS. Furthermore, miR-20b-5p achieved a higher diagnostic accuracy to discriminate non-PanC with early-diabetes from HS (AUC = 0.868; SP = 81%; PPV = 32.1%) compared to the CA 19-9 (AUC = 0.700; SP = 40.0%; PPV = 15.5%), and the joint (miR-20b-5p and CA 19-9) discrimination ability was higher than the one achieved by the CA 19-9 tested alone (AUC = 0.900, p = 0.003). Our data highlighted the association between miR-18a-5p and early-diabetes, and suggested for miR-20b-5p and miR-29 a role in identifying early diabetes in PanC, albeit not as an early manifestation of cancer. MiR-20b-5p as more informative marker than CA 19-9 in distinguishing non-PanC with recent diabetes from HS was also uncovered.https://www.frontiersin.org/article/10.3389/fonc.2020.01567/fullpancreatic cancercirculating microRNAearly diabetesexpression profilediagnostic performance |
| spellingShingle | Francesca Tavano Andrea Fontana Tommaso Mazza Domenica Gioffreda Tommaso Biagini Orazio Palumbo Massimo Carella Angelo Andriulli Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis Frontiers in Oncology pancreatic cancer circulating microRNA early diabetes expression profile diagnostic performance |
| title | Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis |
| title_full | Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis |
| title_fullStr | Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis |
| title_full_unstemmed | Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis |
| title_short | Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis |
| title_sort | early onset diabetes as risk factor for pancreatic cancer mirna expression profiling in plasma uncovers a role for mir 20b 5p mir 29a and mir 18a 5p in diabetes of recent diagnosis |
| topic | pancreatic cancer circulating microRNA early diabetes expression profile diagnostic performance |
| url | https://www.frontiersin.org/article/10.3389/fonc.2020.01567/full |
| work_keys_str_mv | AT francescatavano earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT andreafontana earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT tommasomazza earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT domenicagioffreda earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT tommasobiagini earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT oraziopalumbo earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT massimocarella earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis AT angeloandriulli earlyonsetdiabetesasriskfactorforpancreaticcancermirnaexpressionprofilinginplasmauncoversaroleformir20b5pmir29aandmir18a5pindiabetesofrecentdiagnosis |